effect for sympathetic nerve activity of statin for heart failure with preserved ejection fraction

effect for sympathetic nerve activity of statin for heart failure with preserved ejection fraction - effect for sympathetic nerve activity of statin for heart failure with preserved ejection fraction

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000018611

Enrollment

Registered

2015-09-01

Start date

2015-09-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

chronic heart failure with preserved ejection fraction

Interventions

prescribe atrovastatin prescribe lovastatin

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1) chronic heart failure with preserved EF( >40%) 2) dyslipidemia

Exclusion criteria

Exclusion criteria: 1) stroke 2) AMI within 3 months 3) ACS 4) IP 5) severe valvular desease or shunt desease 6) chronic kidney desease 7)chronic Af 8) DM 9) secondary hypertension

Design outcomes

Primary

Measure	Time frame
regulation of muscle sympathetic nerve activity	—

Countries

Japan

Contacts

Public Contacthideki tokuhisa

kanazawa university department of desease control and homeostasis

hidekitokuhisa@yahoo.co.jp090-2379-7809

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026